Drug Shortage Report for APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE

Last updated on 2020-06-15 History
Report ID 68700
Drug Identification Number 02416255
Brand name APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Common or Proper name ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60BTL
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-03
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-06-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-06-15 French Compare
v7 2020-06-15 English Compare
v6 2020-04-27 French Compare
v5 2020-04-27 English Compare
v4 2019-03-15 French Compare
v3 2019-03-15 English Compare
v2 2018-12-05 French Compare
v1 2018-12-05 English Compare

Showing 1 to 8 of 8